STRATEC
€10,000 invested in 2016 · with dividend reinvestment
Dividend history
About STRATEC
Stratec SE is a Germany-based developer and manufacturer of fully automated analyzer systems for partners in clinical diagnostics and biotechnology. Founded in 1979 and headquartered in Birkenfeld, the company specializes in automation solutions for in-vitro diagnostics and life sciences, including sample preparation, integrated laboratory software, and complex consumables for diagnostic and medical applications. As an original equipment manufacturer (OEM), Stratec SE covers the entire value chain—from specification and design to production and quality assurance—enabling partners to market complete system solutions alongside their reagents to laboratories, blood banks, and research institutes worldwide. Notable innovations include the world’s first fully automated luminescence analyzer in 1989 and ongoing advancements through acquisitions like Diatron MI in 2016 for hematology systems and Natech Plastics in 2023 for polymer-based consumables. With subsidiaries across Europe, the US, China, and beyond, and approximately 1,450 employees, Stratec SE leverages patented technologies to serve major diagnostic firms in the healthcare sector, emphasizing precision and reliability in laboratory automation.